Hybio Pharmaceutical Co., Ltd. (SHE:300199)

Hybio Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 24, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	16,508	11,385	11,994	15,527	11,138	5,917
Market Cap Growth	28.68%	-5.08%	-22.75%	39.41%	88.22%	14.66%
Enterprise Value	18,244	13,122	13,710	17,024	12,784	7,126
Last Close Price	18.69	12.89	13.58	17.58	12.61	6.65
PE Ratio	-	-	-	-	361.52	-
Forward PE	-	9.21	9.21	9.21	9.21	9.21
PS Ratio	22.01	19.29	27.80	22.05	15.13	8.20
PB Ratio	24.77	19.07	15.31	11.97	6.76	3.53
P/TBV Ratio	45.61	39.92	22.37	15.44	8.43	4.48
P/FCF Ratio	285.82	232.96	-	-	-	-
P/OCF Ratio	86.89	69.12	-	982.28	71.02	123.30
PEG Ratio	-	1.00	1.00	1.00	1.00	1.00
EV/Sales Ratio	24.33	22.23	31.78	24.17	17.37	9.87
EV/EBITDA Ratio	96.46	115.59	-	-	-	-
EV/FCF Ratio	315.88	268.51	-	-	-	-
Debt / Equity Ratio	2.67	3.01	2.59	1.39	1.09	1.16
Debt / EBITDA Ratio	9.40	15.72	-	-	-	-
Debt / FCF Ratio	30.77	36.79	-	-	-	-
Asset Turnover	0.25	0.19	0.13	0.19	0.19	0.17
Inventory Turnover	1.86	1.44	1.52	1.12	1.58	0.91
Quick Ratio	0.15	0.14	0.36	0.52	1.28	0.74
Current Ratio	0.31	0.33	0.48	0.71	1.55	0.95
Return on Equity (ROE)	-13.37%	-26.10%	-49.56%	-25.30%	1.71%	-31.16%
Return on Assets (ROA)	0.89%	-0.64%	-6.74%	-3.03%	-4.26%	-7.79%
Return on Capital (ROIC)	1.09%	-0.78%	-7.85%	-3.48%	-4.78%	-8.64%
Return on Capital Employed (ROCE)	3.00%	-	-	-	-	-
Earnings Yield	-0.54%	-1.52%	-4.28%	-2.39%	0.28%	-10.30%
FCF Yield	0.35%	0.43%	-0.71%	-1.12%	-0.38%	-3.31%
Payout Ratio	-	-	-	-	375.37%	-
Buyback Yield / Dilution	-9.72%	2.00%	-0.42%	14.09%	-11.21%	-0.19%
Total Shareholder Return	-	2.00%	-0.42%	14.09%	-11.21%	-0.19%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.